Rafael Meza Department of Epidemiology University of Michigan

Slides:



Advertisements
Similar presentations
1 Comprehensive Cancer Control In Action. What to expect today? Provide state-level forum for networking & sharing your org’s current survivorship initiatives.
Advertisements

CPCRN and NCI Priorities Jon F. Kerner, Ph.D. Deputy Director DCCPS.
Review of Recommendations to the Secretary of Health and Human Service April 16, 2013.
The Greater Cleveland Cancer Prevention Research Collaborating Center Sue Flocke, PhD Case Western Reserve University October 29, 2014 This presentation.
The National Comprehensive Cancer Control Program (NCCCP): Current Progress and Future Action Temeika L. Fairley, Epidemiologist Comprehensive Cancer Control.
Public Health Perspective on Radon Control in Ireland Dr. Ina Kelly Specialist Registrar in Public Health Medicine Health Service Executive Department.
Economic Evaluation of Cancer Screening - Case of Colorectal Cancer – Cost-Effectiveness analysis of stool DNA to Screen for Colorectal Cancer October.
Use of epidemiologic methods in disaster management Dr AA Abubakar Dept of Community Medicine Ahmadu Bello University Zaria Nigeria.
Funding Priorities: National Cancer Institute Carly Parry, PhD, MSW National Cancer Institute.
EVOLVING PUBLIC HEALTH AND HEALTH CARE LANDSCAPE AND OPPORTUNITIES FOR CANCER COMMUNICATION NCI Health Communication and Informatics Research Branch CPCRN.
“Working Together, Reducing Cancer, Saving Lives”
NCI’s Cancer Information Service Program Mary Anne Bright Office of Cancer Information Service, NCI June 25, 2007.
Integrating evidence-based practice into state and national cancer control programs Karen Glanz, PhD, MPH Emory University Cathy Melvin, PhD, MPH University.
Systematic Reviews.
American Cancer Society Prostate Cancer Activities 2007 African American Prostate Cancer Disparity Summit September 28, 2007 Washington, D.C.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES FITBIR: A Platform for International.
XXX_DECRIPT_MON00/1 Quality and impact of Social Science and Operations Research by the Special Programme in Human Reproduction Department of Reproductive.
Alaska Native Tumor Registry Alaska Native Epidemiology Center 40-Year Trends in Cancer Incidence among Alaska Native People
Mississippi Comprehensive Cancer Control Plan (2006 ~ 2011) Overview Mina Li, MD (FMG), MS Director, Comprehensive Cancer Control Mississippi Department.
CISNET and BCSC: Working Together To Model The Population Impact Breast Cancer Screening A Celebration of the Work of the Breast Cancer Surveillance Consortium.
Universal Screening for Lynch Syndrome with Cascade Screening for Relatives September 7, 2012 Deb Duquette, MS, CGC Michigan Department of Community Health.
Systems Approaches to Population Health. Activities Supported by NCI.
University of Iowa Cancer Prevention and Control Research Network Sue Curry, Ph.D., Principal Investigator This presentation was supported by Cooperative.
Slide 1 Community Networks to Reduce Cancer Health Disparities Pre-Application Conference May 26, 2004 Bethesda, MD Kenneth C. Chu, PhD Chief, Disparities.
Data Sources-Cancer Betsy A. Kohler, MPH, CTR Director, Cancer Epidemiology Services New Jersey Department of Health and Senior Services.
Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013.
Modeling Efforts to Inform Countries’ Screening Decisions Ann Graham Zauber, Iris Vogelaar, Marjolein van Ballegooijen, Deb Schrag, Rob Boer, Dik Habbema,
Geographic Visualization to Support Epidemiology in Bulgaria Anthony C. Robinson GeoVISTA Center Department of Geography The Pennsylvania State University.
Georgia Comprehensive Cancer Control Program 3/10/2015 Program Monitoring and Evaluation Activities Short-Term Outcomes Long-Term Outcomes Intermediate.
CT Screening for Lung Cancer vs. Smoking Cessation: A Cost-Effectiveness Analysis Pamela M. McMahon, PhD; Chung Yin Kong, PhD; Bruce E. Johnson; Milton.
Morristown Medical Center ~ Somerset County Department of Health Cancer Coordinator ~ Coalition Members at large Policy and Environmental Change ~Tobacco.
Tobacco/Lung Cancer Working Group Participating Institutions: Case Western Reserve University; University of Washington; University of Iowa; University.
OVERVIEW OF STUDY DESIGN. COMMUNITY SURVEYS
Tools for climate health adaptation planning at the local level
Indiana State Cancer Registry
Ruth Geraghty Data Curator Children’s Research Network
CHS Community Health Survey
Health Promotion & Aging
Florida’s Top 5 Causes of Deaths
WHO Surveillance Tools for NCD Risk Factors – Instruments and Data Sources Surveillance and Population-based Prevention Unit Department for Prevention.
NCD PRESENTATION: JAMAICA
ISO An introduction Part 3
Patient Navigation Process
NATIONAL outreach Network
Juvenile Justice Policy and Oversight Committee
WHO The World Health Survey General Introduction
Non-Communicable Diseases Risk Factors Survey in Georgia
American Cancer Society Workplace Solutions
prevention and control of non communicable diseases in Iraq
Supporting Learning and Organisational Effectiveness
Musculoskeletal Health in Europe
NCI’s Cancer Information Service Program
From: Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations: Methods of the U.S. Preventive Services.
The Effect of Key Organizational Attributes on Cancer Screening Rates
Broadening Eligibility Criteria to Make Clinical Trials More Representative Joint Recommendations of the American Society of Clinical Oncology and Friends.
Background & Objectives
Institute of Public Health, Environment and Health Department
ISO An introduction Part 3
Ruth Geraghty Data Curator Children’s Research Network
Society Perspective 07 SEPT 2018
Purposes of a Tobacco-Related Surveillance System
Standard 3.1 Patient Navigation Process
Prepared by staff in Prevention and Cancer Control.
Department of Computer Science, University of Tennessee, Knoxville
Nurses making a difference in tobacco dependence treatment in Portugal
A strategic approach to data development and data sharing in the social sciences Peter Elias NCRM/SRA Workshop: "Data Linkage: Exploring the Potential"
Challenges in Evaluating Screening & Prevention Interventions
Dr Timothy Armstrong Coordinator
NAACCR/IACR Annual Conference, June 2019
Tools to support development of interventions Soili Larkin & Mohammed Vaqar Public Health England West Midlands.
Presentation transcript:

Rafael Meza Department of Epidemiology University of Michigan Experiences Sharing Data and Models from a Multi-Institutional Cancer Modeling Consortium Rafael Meza Department of Epidemiology University of Michigan 1

CISNET Cancer Intervention and Surveillance Modeling Network NCI-sponsored collaborative consortium of simulation modelers in breast, prostate, colorectal, lung, and esophageal cancers formed in 2000 Funded through a U01 (collaborative agreement) mechanism Use surveillance, epidemiology, clinical data and simulation modeling to guide public health research and priorities http://cisnet.cancer.gov

CISNET Lung Group Six lung cancer models: Smoking and lung cancer Erasmus, Georgetown, MGH, Michigan, Stanford and Yale Smoking and lung cancer Reconstruction of smoking histories in the US Impact of tobacco control on lung cancer outcomes and overall mortality Lung cancer screening Extrapolation of NLST/PLCO trial results to the US Assessment of alternative lung cancer screening strategies

Why so many models? The more the merrier? Comparative modeling approach “Independent” models but with comparable inputs and outputs Heterogeneity in model assumptions / data sources Address model misspecification When consensus can be reached, it greatly enhances the credibility of modeling results by highlighting their reproducibility

Why so many models? Comparative modeling approach – cont. When results are disparate, it can help to pinpoint areas where our knowledge base is insufficient and further research is needed Comparative modeling is a powerful tool that would be impossible without a collaborative effort within the scientific community Cited by the International Society Pharmacoeconomics and Outcomes Research Modeling TF as example of good modeling practices

Fred Hutchinson Lung Cancer Model – Model F Meza, ten Haaf et al, Cancer in press

Erasmus-MISCAN Model – Model E

MGH-HMS Lung Cancer Policy Model – Model M Meza, ten Haaf et al, Cancer in press

Stanford Natural History Model of Lung Cancer – Model S Meza, ten Haaf et al, Cancer in press

apm bpm m0 m1 apc bpc mpm lIA1 lIA2 lIB lII lIIIA lIIIB IA1 IA2 IB II Michigan Lung Cancer screening model – Model U By gender and histology (SC,AC,SQ,ONSCLC) Normal X Preinitiated Pre malignant apm bpm m0 m1 Preclinical apc bpc mpm Preclinical lIA1 lIA2 lIB lII lIIIA lIIIB IA1 IA2 IB II IIIA IIIB IV dIA1 dIB dII dIIIA dIIIB dIV dIA2 Clinical Detection Meza, ten Haaf et al, Cancer in press

Computational / Data / Documentation Issues 6 independent models Computational implementation Shared know-how Sharing inputs Large datasets, eg, large-scale screening clinical trials Input simulators, eg, smoking history generator Producing same outputs – to be compared Processing outputs from multiple models Result dissemination Common documentation – model profiler Model sharing / model real-time “running”

Collaboration tools

Shared Input Generator Smoking History Generator Microsimulation of individual smoking histories C++ code Inputs based on analysis of historical data on smoking patterns – 50 years of annual national cross-sectional surveys

Holford et al, AJPM 2014

Holford et al, AJPM 2014

Holford et al, AJPM 2014

CISNET public resources Historical US rates of initiation, cessation, cigarettes per day by gender, age and birth cohort Interactive graphs from publications https://resources.cisnet.cancer.gov/projects/

Simulating smoking related health outcomes Some groups use macro (population) models Others use microsimulations: Generate smoking histories for (large) N individuals for each birth-cohort from 1864-2050 using the SHG Use individual histories as inputs for lung cancer models Lung cancer incidence/mortality, overall mortality, impact of screening Large scale computations model calibrations / intervention simulation

High-Performance Computing Experiences Some groups run their models on their own PCs Others in Linux/Unix clusters Most run in single threads, but at least one or two groups have done some parallelization The Michigan group has compiled the SHG in the high-performance UM Flux cluster and is working on parallelizing the SHG and its tobacco control policies module Parallelization in a single processor multi-core workstation

McMahon et al, Plos One 2014

Sharing tools – publication support

Tobacco Policy Tool - Dissemination

Conclusions Examples of computational tools to support collaborative process Sharing inputs, models, outputs Modeling limited by computational power DOE collaboration Basis for new Center for the Assessment of the Public Health Impact of Tobacco Regulations proposal (U54)